🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, global, Phase 2, open-label, 2-part, first-line stud...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center
Start Date
2019-08-29
Trial ID
NCT03929666
This is a multicenter, open-label, prospective, single-arm, phase II study ...
Status
Recruiting
Location
Fujian Medical University Union Hospital
Start Date
2025-10-25
Trial ID
NCT07296705
Treatments Being Tested
The ZANGEA trial is a open-label, single arm, multicenter phase II trial as...
Status
Recruiting
Location
Charité CVK
Start Date
2026-01-16
Trial ID
NCT07176312
Treatments Being Tested
This is a phase II open-label study to evaluate the efficacy and safety of ...
Status
Not Yet Recruiting
Location
Xijing Hospital, Air Force Medical University
Start Date
2026-07
Trial ID
NCT07685704
Treatments Being Tested
This study will test a new personalized treatment approach for patients wit...
Status
Recruiting
Location
University of California, Los Angeles
Start Date
2026-07-20
Trial ID
NCT07290985
Treatments Being Tested
This is a Phase 1/1b open-label, multi-center dose escalation and dose opti...
Status
Recruiting
Location
UCSD Moores Cancer Center
Start Date
2024-03-25
Trial ID
NCT06253871
Treatments Being Tested
This multicenter, open-label, single-arm trial will evaluate the anti-tumor...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2020-10-01
Trial ID
NCT04466891
Treatments Being Tested
This is an open-label, multicenter, extension study to evaluate the long-te...
Status
Completed
Location
Mount Sinai Medical Center Braman Comprehensive Cancer Center
Start Date
2019-12-19
Trial ID
NCT04164199
Alterations in the HER2 gene are involved in the development of cancer. The...
Status
Recruiting
Location
Institut de Cancérologie de l'Ouest
Start Date
2025-10-30
Trial ID
NCT07192068
Treatments Being Tested
I-SPY Phase I/Ib (I-SPY-P1) is an open-label, multisite platform study desi...
Status
Recruiting
Location
The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center
Start Date
2023-02-15
Trial ID
NCT05868226
Treatments Being Tested